選択的エストロゲン受容体分解薬 (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "選択的エストロゲン受容体分解薬" in Japanese language version.

refsWebsite

Global rank Japanese rank

6nih.gov

4^th place

24^th place

4doi.org

2^nd place

6^th place

2worldcat.org

5^th place

19^th place

1nii.ac.jp

304^th place

20^th place

1jst.go.jp

1,903^rd place

237^th place

1acs.org

1,248^th place

1,765^th place

1practiceupdate.com

low place

1evaluate.com

low place

1g1therapeutics.com

low place

1lww.com

2,769^th place

4,586^th place

1ascopubs.org

low place

acs.org

pubs.acs.org

Lu, Yunlong; Liu, Wukun (2020-12-24). “Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast Cancer” (英語). Journal of Medicinal Chemistry 63 (24): 15094–15114. doi:10.1021/acs.jmedchem.0c00913. ISSN 0022-2623.

ascopubs.org

Bardia, Aditya; Linden, Hannah M.; Ulaner, Gary A.; Chandarlapaty, Sarat; Gosselin, Alice; Celanovic, Marina; Campone, Mario (2019-05-20). “Phase 1/2 dose-escalation and expansion study investigating SAR439859 +/- palbociclib in postmenopausal women with estrogen receptor-positive (ER+)/HER2- metastatic breast cancer.”. Journal of Clinical Oncology 37 (15_suppl): TPS1105. doi:10.1200/JCO.2019.37.15_suppl.TPS1105. ISSN 0732-183X.

doi.org

Lee, CI; Goodwin, A; Wilcken, N (3 January 2017). “Fulvestrant for hormone-sensitive metastatic breast cancer.”. The Cochrane Database of Systematic Reviews 1: CD011093. doi:10.1002/14651858.CD011093.pub2. PMC 6464820. PMID 28043088.
Lu, Yunlong; Liu, Wukun (2020-12-24). “Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast Cancer” (英語). Journal of Medicinal Chemistry 63 (24): 15094–15114. doi:10.1021/acs.jmedchem.0c00913. ISSN 0022-2623.
Lai, AC; Crews, CM (25 November 2016). “Induced protein degradation: an emerging drug discovery paradigm.”. Nature Reviews. Drug Discovery 16 (2): 101–114. doi:10.1038/nrd.2016.211. PMC 5684876. PMID 27885283.
Bardia, Aditya; Linden, Hannah M.; Ulaner, Gary A.; Chandarlapaty, Sarat; Gosselin, Alice; Celanovic, Marina; Campone, Mario (2019-05-20). “Phase 1/2 dose-escalation and expansion study investigating SAR439859 +/- palbociclib in postmenopausal women with estrogen receptor-positive (ER+)/HER2- metastatic breast cancer.”. Journal of Clinical Oncology 37 (15_suppl): TPS1105. doi:10.1200/JCO.2019.37.15_suppl.TPS1105. ISSN 0732-183X.

evaluate.com

“A blockbuster breast cancer niche has Roche and Sanofi in the lead” (英語). Evaluate.com (2020年2月19日). 2020年12月28日閲覧。

g1therapeutics.com

“Rintodestrant | oral selective estrogen receptor degrader (SERD) | G1 Therapeutics, Inc.”. www.g1therapeutics.com. 2021年1月9日閲覧。

jst.go.jp

jglobal.jst.go.jp

正田卓司、藤里卓磨、藤里卓磨、三澤隆史、出水庸介、井上英史、内藤幹彦、栗原正明「選択的エストロゲン受容体分解薬の分子設計」『日本薬学会年会要旨集(CD-ROM)』137th、2017年、27–37頁。

lww.com

know.lww.com

“Orally Bioavailable SERD Shows Promise in Certain Breast Cancer Patients”. know.lww.com. 2021年1月9日閲覧。

nih.gov

nii.ac.jp

kaken.nii.ac.jp

“選択的エストロゲン受容体分解薬の効率的分子デザイン法の開発”. 2022年1月1日閲覧。

practiceupdate.com

“Injection-Site Pain With Large-Volume Intramuscular Injection of Fulvestrant Can Be Minimized” (英語). PracticeUpdate. 2020年12月28日閲覧。

worldcat.org

search.worldcat.org

Lu, Yunlong; Liu, Wukun (2020-12-24). “Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast Cancer” (英語). Journal of Medicinal Chemistry 63 (24): 15094–15114. doi:10.1021/acs.jmedchem.0c00913. ISSN 0022-2623.
Bardia, Aditya; Linden, Hannah M.; Ulaner, Gary A.; Chandarlapaty, Sarat; Gosselin, Alice; Celanovic, Marina; Campone, Mario (2019-05-20). “Phase 1/2 dose-escalation and expansion study investigating SAR439859 +/- palbociclib in postmenopausal women with estrogen receptor-positive (ER+)/HER2- metastatic breast cancer.”. Journal of Clinical Oncology 37 (15_suppl): TPS1105. doi:10.1200/JCO.2019.37.15_suppl.TPS1105. ISSN 0732-183X.

選択的エストロゲン受容体分解薬 (Japanese Wikipedia)

acs.org

pubs.acs.org

ascopubs.org

doi.org

evaluate.com

g1therapeutics.com

jst.go.jp

jglobal.jst.go.jp

lww.com

know.lww.com

nih.gov

ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov

pubmed.ncbi.nlm.nih.gov

nii.ac.jp

kaken.nii.ac.jp

practiceupdate.com

worldcat.org

search.worldcat.org